It was a pleasure to present in the Melvin Judkins Early Career Clinical Investigator Award session at #AHA25 (hosted by @americanheart.bsky.social) and to serve as a #SoMe ambassador for @accintouch.bsky.social and @jaccjournals.bsky.social!

Proud to have represented @uclpophealthsci.bsky.social!

🚨 #AHA2025- CorCMR study: In patients with chest pain + non-obstructive coronary arteries, stress #whyCMR diagnosed microvascular angina in 50% vs <1% with angiogram alone. QoL improved 22 vs <1 point at 1 year.

Read more: shorturl.at/JymI9

@accintouch.bsky.social @jaccjournals.bsky.social

#AHA25: With ⬆️ BP continuing to be a 🌍 challenge, effective management must remain a global priority. The results from BETTER-BP 👇, GOFRESH & Healthy Family offer 3 strategies targeting behavior, diet & family that could inform larger-scale programs.

🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky

#AHA25: Mixed results for post-#Afib ablation care

❌ DARE-AF: dapagliflozin didn’t ⬇️ early #Afib recurrence.

✅ META-AF: Metformin ⬇️ recurrent #Afib in obese, non-diabetic pts at 1 yr.

💡 GLP-1 agonists next?

Full story: shorturl.at/SeCFP

@accintouch.bsky.social @jaccjournals.bsky.social

ANSWER-HF at #AHA25: RCT of sacubitril-valsartan vs enalapril in Chagas HF (n=190, 6-mo). LVEF ↑ 2.1% vs 1.2% (NS). NT-proBNP ↓32% vs enalapril (p<0.001). Win ratio 1.80 favors sac/val.

Read more: bit.ly/43mv5oh!

@jaccjournals.bsky.social @accintouch.bsky.social

Hear insights from #ACCPresident Christopher M. Kramer, MD, FACC, on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care.

Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social

#AHA25 AFib shake-up 🫀⚡

OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok.

ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins.

CLOSURE: meds > LAAC in high-risk.

Read more: shorturl.at/jVkk1

@jaccjournals.bsky.social @accintouch.bsky.social

🚨New at #AHA25 & in #JACC: In the MAPLE-HCM trial, those with obstructive #HCM treated with aficamten showed superior improvements vs. metoprolol in:

🫀HF symptoms
💪 Exercise capacity
⚡LVOT gradient
💬 Health status

Read more: tinyurl.com/yez2ybss

@accintouch.bsky.social @jaccjournals.bsky.social

#VESALIUSCV at #AHA25: In >12,000 high-risk pts w/o prior MI or stroke, evolocumab cut risk of CHD death, MI, or ischemic stroke (HR ~0.75) & 4-pt MACE (HR ~0.81) over ~4.5 yrs. LDL-C ↓ ~55% to ~45 mg/dL.

Read more: shorturl.at/0LsXi

@accintouch.bsky.social @jaccjournals.bsky.social

First-in-human #CRISPR trial at #AHA25 🚀 One-time infusion targeting ANGPTL3 was safe and lowered both LDL-C & triglycerides.

🧬 Read more: bit.ly/47Nfb7O
@accintouch.bsky.social @jaccjournals.bsky.social

🆕 #JACC Leadership Page from #ACCPresident @chriskramermd.bsky.social and ACC leaders Drs. Malissa J. Wood and Sandra J. Lewis emphasize the value of intentional investment in leadership development ➕ non-clinical competencies.

Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky

#AHA25 starts today! As a JACC Social Media Ambassador, I'll be posting live updates and key takeaways.

@accintouch.bsky.social
@jaccjournals.bsky.social

Magnetic resonance imaging (MRI) scans of the heart could help to detect lamin heart disease earlier and enable clinicians to better predict which patients are most at risk, finds a new study led by Dr Cristian Topriceanu @ctopriceanu.bsky.social and Dr Gaby Captur @uclpophealthsci.bsky.social

Magnetic resonance imaging (MRI) scans of the heart could help to detect lamin heart disease earlier and enable clinicians to better predict which patients are most at risk, finds a new study led by Dr Cristian Topriceanu @ctopriceanu.bsky.social and Dr Gaby Captur

✈️ Is aircraft noise bad for your heart?🫀

Exposure to higher aircraft noise is linked to adverse heart changes by #WhyCMR, potentially increasing the risk of #MACE.

Full paper @jaccjournals.bsky.social: tinyurl.com/5yx7j49b

@uclpophealthsci.bsky.social